KAMADA
"KAMADA" is a word and design mark owned by Kamada Ltd., filed at the USPTO on May 13, 2025. It is registered and covers class 5 (Pharmaceuticals).
- Status
- Registered
- Since May 26, 2026
- Filed
- May 13, 2025
- Registered
- May 26, 2026
- Priority date
- May 10, 2025
- Claimed from Israel
- Application no.
- 99182288
- Registration no.
- 8269282
- Office
- USPTO
- United States Patent and Trademark Office
- Mark type
- Word and design
- 1 class
Who owns KAMADA
The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.
Owner
Kamada Ltd.
Rehovot, Israel
Representative
Ben Natter
Haug Partners, LLP
What the mark covers
The products and services KAMADA is filed for, grouped by Nice class.
Pharmaceuticals, namely, plasma derived and recombinant immunoglobulins for use in the treatment of infectious diseases, namely, CMV disease, Hepatitis B, Varicella Zoster, and rabies, Hematologic conditions including Idiopathic Thrombocytopenic Purpura; Respiratory conditions including Alpha-1 Antitrypsin Deficiency, Obstetrics and Gynecology conditions such as hemolytic disease of the newborn, Transplantation treatments including solid-organ transplants and hematopoietic stem-cell transplantation; pharmaceuticals namely plasma derived and recombinant proteins for treating pulmonary diseases, congenital Alpha-1 Antitrypsin deficiency, post-exposure prophylaxis against viral infection, preventing and treating immune tolerance based diseases, treating immunological disorders and treating inflammatory diseases; pharmaceuticals namely coagulation factors for bleeding disorders; plasma-derived protein preparations for therapeutic use; vaccines; pharmaceutical preparations for the treatment of lung diseases; pharmaceutical preparations for the treatment or prevention of thromboembolic disorders; pharmaceutical preparations for anesthesia analgesia for surgery; pharmaceutical preparations for treatment of CMV infection and disease; pharmaceutical preparations for the treatment of Varicella Zoster Virus; pharmaceutical preparations for treatment of Hepatitis; pharmaceutical preparations for the treatment of Rabies
What has happened so far
Steps recorded by the USPTO, newest first.
- Notice of registration confirmation emailed
- Registered-principal register
- Official gazette publication confirmation e-mailed
- Published for opposition
- Notification of notice of publication e-mailed
- Approved for pub - principal register
- Teas/email correspondence entered
- Correspondence received in law office
- Teas response to suspension inquiry received
- Notification of letter of suspension e-mailed
10 earlier steps on the official record.
About KAMADA
Who owns the trademark "KAMADA"?
The USPTO trademark "KAMADA" (application 99182288) is owned by Kamada Ltd.
What is the status of "KAMADA"?
Its status at the USPTO is: registered.
When was "KAMADA" registered?
It was registered on May 26, 2026.
Get this data via the API
Everything on this page comes from the Signa API. Pull KAMADA and marks like it into your own product with one request.
GET/v1/trademarks/{id}The full record: owners, classes, dates and images
GET/v1/trademarks/{id}/eventsEvery step in the office history
GET/v1/proceedings?trademark_id={id}Oppositions and cancellations against the mark
ID=tm_019d2ac5-32f3-76bb-9981-8097f25e9ef7
curl https://api.signa.so/v1/trademarks/$ID \
-H "Authorization: Bearer $SIGNA_API_KEY"{
"id": "tm_019d2ac5-32f3-76bb-9981-8097f25e9ef7",
"object": "trademark",
"mark_text": "KAMADA",
"status": {
"primary": "active",
"stage": "registered"
},
"office_code": "US",
"application_number": "99182288",
"filing_date": "2025-05-13",
"nice_classes": [
5
],
"owners": [
{
"name": "Kamada Ltd.",
"entity_id": "ent_019eb7c3-846b-764c-bae3-b12eb2c7bf3e"
}
]
}